Top compounds associated with response to C6orf223


Feature Type Standardized
Nominal ANOVA
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.085 0.008
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.14 0.009
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.083 0.009
mRNA lovastatin CTRPv2 pan-cancer AAC -0.097 0.009
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.009
mRNA clofarabine CTRPv2 pan-cancer AAC 0.077 0.01
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.095 0.01
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.01
mRNA AT13387 CTRPv2 pan-cancer AAC 0.12 0.01
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.085 0.01
Download CSV